BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22129388)

  • 1. Synbiotics in health and disease.
    Kolida S; Gibson GR
    Annu Rev Food Sci Technol; 2011; 2():373-93. PubMed ID: 22129388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European market developments in prebiotic- and probiotic-containing foodstuffs.
    Young J
    Br J Nutr; 1998 Oct; 80(4):S231-3. PubMed ID: 9924290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotics, their health benefits and applications for developing healthier foods: a review.
    Nagpal R; Kumar A; Kumar M; Behare PV; Jain S; Yadav H
    FEMS Microbiol Lett; 2012 Sep; 334(1):1-15. PubMed ID: 22568660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galactooligosaccharides: novel components of designer foods.
    Sangwan V; Tomar SK; Singh RR; Singh AK; Ali B
    J Food Sci; 2011 May; 76(4):R103-11. PubMed ID: 22417365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prebiotics, synbiotics and inflammatory bowel disease.
    Steed H; Macfarlane GT; Macfarlane S
    Mol Nutr Food Res; 2008 Aug; 52(8):898-905. PubMed ID: 18383235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of pre- and/or probiotics on human colonic metabolism: does it affect human health?
    De Preter V; Hamer HM; Windey K; Verbeke K
    Mol Nutr Food Res; 2011 Jan; 55(1):46-57. PubMed ID: 21207512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of probiotics, prebiotics, and synbiotics on growth factors in the large bowel in a rat model of formula-induced bowel inflammation.
    Fordjour L; D'Souza A; Cai C; Ahmad A; Valencia G; Kumar D; Aranda JV; Beharry KD
    J Pediatr Gastroenterol Nutr; 2010 Oct; 51(4):507-13. PubMed ID: 20683203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Probioticss, prebiotics,synbiotics and eubiotics].
    Zoppi G
    Pediatr Med Chir; 1998; 20(1):13-7. PubMed ID: 9658415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probiotics, prebiotics, and synbiotics.
    de Vrese M; Schrezenmeir J
    Adv Biochem Eng Biotechnol; 2008; 111():1-66. PubMed ID: 18461293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional oligosaccharides: application and manufacture.
    Rastall RA
    Annu Rev Food Sci Technol; 2010; 1():305-39. PubMed ID: 22129339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapies aimed at the gut microbiota and inflammation: antibiotics, prebiotics, probiotics, synbiotics, anti-inflammatory therapies.
    Quigley EM
    Gastroenterol Clin North Am; 2011 Mar; 40(1):207-22. PubMed ID: 21333908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro screening of probiotic lactic acid bacteria and prebiotic glucooligosaccharides to select effective synbiotics.
    Grimoud J; Durand H; Courtin C; Monsan P; Ouarné F; Theodorou V; Roques C
    Anaerobe; 2010 Oct; 16(5):493-500. PubMed ID: 20670686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microecology as a target for therapeutic intervention in inflammatory bowel disease.
    Guarner F
    IDrugs; 2003 Sep; 6(9):868-73. PubMed ID: 12964066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotics, prebiotics, and synbiotics: impact on the gut immune system and allergic reactions.
    Gourbeyre P; Denery S; Bodinier M
    J Leukoc Biol; 2011 May; 89(5):685-95. PubMed ID: 21233408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prebiotics in inflammatory bowel diseases.
    Guarner F
    Br J Nutr; 2007 Oct; 98 Suppl 1():S85-9. PubMed ID: 17922967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Food-based strategies to modulate the composition of the intestinal microbiota and their associated health effects.
    Bosscher D; Breynaert A; Pieters L; Hermans N
    J Physiol Pharmacol; 2009 Dec; 60 Suppl 6():5-11. PubMed ID: 20224145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: Probiotics in gastrointestinal and liver diseases.
    Jonkers D; Stockbrügger R
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():133-48. PubMed ID: 18081657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease.
    Mitsuyama K; Sata M
    Expert Opin Ther Targets; 2008 Mar; 12(3):301-12. PubMed ID: 18269340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation in human volunteers of the potential anticarcinogenic activities of novel nutritional concepts: prebiotics, probiotics and synbiotics (the SYNCAN project QLK1-1999-00346).
    Van Loo J; Jonkers N
    Nutr Metab Cardiovasc Dis; 2001 Aug; 11(4 Suppl):87-93. PubMed ID: 11894762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probiotics, prebiotics, synbiotics: is there enough evidence to support their use in colorectal cancer surgery?
    Peitsidou K; Karantanos T; Theodoropoulos GE
    Dig Surg; 2012; 29(5):426-38. PubMed ID: 23258276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.